TY - JOUR
T1 - Vaccinating adults at risk for pneumococcal disease in the hospital setting: a pilot study
AU - De Waure, Chiara
AU - Calabro', Giovanna Elisa
AU - Nicolazzi, Maria Anna
AU - Moretti, Tiziana
AU - Di Nardo, Francesco
AU - Landolfi, Raffaele
AU - Ricciardi, Walter
PY - 2015
Y1 - 2015
N2 - Worldwide, Streptococcus Pneumoniae is responsible for a
considerable burden of illness especially in elderly and in
people affected by chronic diseases. Vaccination reduces the
burden of disease and two vaccines are currently available: a
polysaccharide (PPV23) and a conjugate one (PCV13).
Notwithstanding national recommendations to vaccinate
people at risk, reaching them is not easy, especially in
adulthood. For this reason a project was launched in Italy
with an unrestricted grant of Pfizer in order to catch people at
risk in the hospital setting.
Description of the problem
Vaccination of adults at risk is a relevant challenge for Public
Health. The primary goal of this study is to estimate the
prevalence of people at risk for pneumococcal diseases who
have access to the hospital and are not vaccinated and to offer
them the opportunity to be vaccinated in the hospital. For this
purpose, all patients 50 years old or older who are admitted to
the Department of Medical Sciences of the Teaching Hospital
‘A. Gemelli’ are interviewed through a questionnaire in order
to identify eligibility to vaccination and, in that case, offer
them PCV13.
Results
The project is ongoing but, at the present, it is showing that the
prevalence of people at risk for pneumococcal diseases
admitted to the hospital is very high and that the most of
them did not receive any recommendation to be vaccinated.
Beyond providing epidemiological data, the project is expected
to increase the awareness of the need of vaccination, to provide
eligible people with the vaccine and to support decision
making in the identification of new strategies for setting up
vaccination programs.
Lessons
Pneumococcal vaccination has been already proved to reduce
the incidence of pneumococcal diseases and to be costeffective.
This project will contribute to increase the knowledge
of the current status of pneumococcal vaccination and its
awareness and to disclose possible ways to increase vaccination
coverage.
Key messages
People who are at high risk for pneumococcal diseases often
do not receive recommendation to be vaccinated and may
be easily observed in the hospital
Capturing adults at risk for pneumococcal disease in the
hospital setting may represent an effective strategy to
increase the vaccination coverage and to offer a better
integrated healthcare
AB - Worldwide, Streptococcus Pneumoniae is responsible for a
considerable burden of illness especially in elderly and in
people affected by chronic diseases. Vaccination reduces the
burden of disease and two vaccines are currently available: a
polysaccharide (PPV23) and a conjugate one (PCV13).
Notwithstanding national recommendations to vaccinate
people at risk, reaching them is not easy, especially in
adulthood. For this reason a project was launched in Italy
with an unrestricted grant of Pfizer in order to catch people at
risk in the hospital setting.
Description of the problem
Vaccination of adults at risk is a relevant challenge for Public
Health. The primary goal of this study is to estimate the
prevalence of people at risk for pneumococcal diseases who
have access to the hospital and are not vaccinated and to offer
them the opportunity to be vaccinated in the hospital. For this
purpose, all patients 50 years old or older who are admitted to
the Department of Medical Sciences of the Teaching Hospital
‘A. Gemelli’ are interviewed through a questionnaire in order
to identify eligibility to vaccination and, in that case, offer
them PCV13.
Results
The project is ongoing but, at the present, it is showing that the
prevalence of people at risk for pneumococcal diseases
admitted to the hospital is very high and that the most of
them did not receive any recommendation to be vaccinated.
Beyond providing epidemiological data, the project is expected
to increase the awareness of the need of vaccination, to provide
eligible people with the vaccine and to support decision
making in the identification of new strategies for setting up
vaccination programs.
Lessons
Pneumococcal vaccination has been already proved to reduce
the incidence of pneumococcal diseases and to be costeffective.
This project will contribute to increase the knowledge
of the current status of pneumococcal vaccination and its
awareness and to disclose possible ways to increase vaccination
coverage.
Key messages
People who are at high risk for pneumococcal diseases often
do not receive recommendation to be vaccinated and may
be easily observed in the hospital
Capturing adults at risk for pneumococcal disease in the
hospital setting may represent an effective strategy to
increase the vaccination coverage and to offer a better
integrated healthcare
KW - Elderly
KW - Pneumococcal vaccines
KW - Elderly
KW - Pneumococcal vaccines
UR - http://hdl.handle.net/10807/71432
M3 - Conference article
SN - 1101-1262
SP - 154
EP - 154
JO - European Journal of Public Health
JF - European Journal of Public Health
T2 - 8th European Public Health Conference
Y2 - 14 October 2015 through 17 October 2015
ER -